Long-term oncological outcomes for HALS/Hybrid vs pure laparoscopic approach in colorectal liver metastases: a propensity score matched analysis.


Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
05 2023
Historique:
received: 14 08 2022
accepted: 06 01 2023
medline: 5 5 2023
pubmed: 30 1 2023
entrez: 29 1 2023
Statut: ppublish

Résumé

Studies comparing hand-assisted laparoscopic (HALS)/Hybrid and pure laparoscopic (PLS) resection for colorectal cancer liver metastasis have focused on short-term results, while long-term oncological outcomes remain understudied. We established a multi-institutional retrospective cohort study from four centers with experience in minimally invasive surgery between 2004 and 2020. Primary endpoints were overall survival (OS) and disease-free survival (DFS). Other endpoints analyzed were intraoperative and postoperative outcomes. Propensity score matching (PSM) was used to minimize baseline differences. A total of 219 HALS/Hybrid (57.8%) and 160 PLS (42.2%) patients were included. After PSM, 155 patients remained in each group. Operative time (182 vs. 248 min, p = 0.012), use of intraoperative ablation (12.3 vs. 4.5%, p = 0.024), positive resection margin (4.5 vs 13.2%, p = 0.012), and pringle time (21 vs. 37 min, p = 0.001) were higher in PLS group. DFS at 1, 3, 5, and 7 years in HALS/Hybrid and PLS groups were 65.4%, 39.3%, 37.5%, and 36.3% vs. 64.9%, 38.0%, 33.1%, and 33.1%, respectively (p = 0.84). OS at 1, 3, 5, and 7 years in HALS/Hybrid and PLS groups were 94.5%, 71.4%, 54.3%, and 46.0% vs. 96.0%, 68.5%, 51.2%, and 41.2%, respectively (p = 0.73). Our study suggests no differences in long-term oncologic outcomes between the two techniques. We discovered that longer total operative, pringle time, higher rates of intraoperative ablation, and positive resection margins were associated with PLS. These differences in favor of HALS/Hybrid could be due to a shorter learning curve and a greater ability to control hemorrhage.

Sections du résumé

BACKGROUND
Studies comparing hand-assisted laparoscopic (HALS)/Hybrid and pure laparoscopic (PLS) resection for colorectal cancer liver metastasis have focused on short-term results, while long-term oncological outcomes remain understudied.
METHODS
We established a multi-institutional retrospective cohort study from four centers with experience in minimally invasive surgery between 2004 and 2020. Primary endpoints were overall survival (OS) and disease-free survival (DFS). Other endpoints analyzed were intraoperative and postoperative outcomes. Propensity score matching (PSM) was used to minimize baseline differences.
RESULTS
A total of 219 HALS/Hybrid (57.8%) and 160 PLS (42.2%) patients were included. After PSM, 155 patients remained in each group. Operative time (182 vs. 248 min, p = 0.012), use of intraoperative ablation (12.3 vs. 4.5%, p = 0.024), positive resection margin (4.5 vs 13.2%, p = 0.012), and pringle time (21 vs. 37 min, p = 0.001) were higher in PLS group. DFS at 1, 3, 5, and 7 years in HALS/Hybrid and PLS groups were 65.4%, 39.3%, 37.5%, and 36.3% vs. 64.9%, 38.0%, 33.1%, and 33.1%, respectively (p = 0.84). OS at 1, 3, 5, and 7 years in HALS/Hybrid and PLS groups were 94.5%, 71.4%, 54.3%, and 46.0% vs. 96.0%, 68.5%, 51.2%, and 41.2%, respectively (p = 0.73).
CONCLUSION
Our study suggests no differences in long-term oncologic outcomes between the two techniques. We discovered that longer total operative, pringle time, higher rates of intraoperative ablation, and positive resection margins were associated with PLS. These differences in favor of HALS/Hybrid could be due to a shorter learning curve and a greater ability to control hemorrhage.

Identifiants

pubmed: 36710284
doi: 10.1007/s00464-023-09873-3
pii: 10.1007/s00464-023-09873-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3861-3872

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Kabir T, Syn N, Goh BKP (2020) Current status of laparoscopic liver resection for the management of colorectal liver metastases. J Gastrointest Oncol 11:526–539
doi: 10.21037/jgo.2020.02.05 pubmed: 32655931 pmcid: 7340801
Guilbaud T, Marchese U, Gayet B, Fuks D (2019) Highlights, limitations and future challenges of laparoscopic resection for colorectal liver metastases. J Visc Surg 156:329–337
doi: 10.1016/j.jviscsurg.2019.04.006 pubmed: 31101548
Barkhatov L, Aghayan DL, Scuderi V, Cipriani F, Fretland ÅA, Kazaryan AM, Ratti F et al (2022) Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study. Surg Endosc 36:3374–3381
doi: 10.1007/s00464-021-08655-z pubmed: 34462867
Abu Hilal M, Underwood T, Zuccaro M, Primrose J, Pearce N (2010) Short- and medium-term results of totally laparoscopic resection for colorectal liver metastases. Br J Surg 97:927–933
doi: 10.1002/bjs.7034 pubmed: 20474003
Abu Hilal M, Aldrighetti L, Dagher I, Edwin B, Troisi RI, Alikhanov R, Aroori S et al (2018) The Southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation. Ann Surg 268:11–18
doi: 10.1097/SLA.0000000000002524 pubmed: 29064908
Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, Koffron AJ et al (2009) The international position on laparoscopic liver surgery: the Louisville statement, 2008. Ann Surg 250:825–830
doi: 10.1097/SLA.0b013e3181b3b2d8 pubmed: 19916210
Wakabayashi G, Cherqui D, Geller DA, Buell JF, Kaneko H, Han HS, Asbun H et al (2015) Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg 261:619–629
pubmed: 25742461
Giglio MC, Troisi RI (2021) Laparoscopic surgery for colorectal liver metastases: moving forward while keeping feet on the ground. Hepatobiliary Surg Nutr 10:107–109
doi: 10.21037/hbsn.2020.04.06 pubmed: 33575296 pmcid: 7867729
Akahoshi S, Beppu T, Mori Y, Kinoshita K, Sato N, Kikuchi K (2020) Does laparoscopic liver resection for colorectal liver metastases provide a true survival benefit compared with open liver resection? Hepatobiliary Surg Nutr 9:657–660
doi: 10.21037/hbsn.2020.01.01 pubmed: 33163518 pmcid: 7603921
Antonetti MC, Killelea B, Orlando R 3rd (2002) Hand-assisted laparoscopic liver surgery. Arch Surg 137:407–411 
doi: 10.1001/archsurg.137.4.407 pubmed: 11926943
Rodgers MS, Windsor JA, Koea JB, McCall JL (2003) Laparoscopic staging of upper gastrointestinal malignancy. ANZ J Surg 73:806–810
doi: 10.1046/j.1445-2197.2003.02789.x pubmed: 14525571
Thaler K, Kanneganti S, Khajanchee Y, Wilson C, Swanstrom L, Hansen PD (2005) The evolving role of staging laparoscopy in the treatment of colorectal hepatic metastasis. Arch Surg 140:727–734
doi: 10.1001/archsurg.140.8.727 pubmed: 16103281
Huang MT, Wei PL, Wang W, Li CJ, Lee YC, Wu CH (2009) A series of laparoscopic liver resections with or without HALS in patients with hepatic tumors. J Gastrointest Surg 13:896–906
doi: 10.1007/s11605-009-0834-6 pubmed: 19277797
Robles R, Marín C, Abellán B, López A, Pastor P, Parrilla P (2008) A new approach to hand-assisted laparoscopic liver surgery. Surg Endosc 22:2357–2364
doi: 10.1007/s00464-008-9770-x pubmed: 18322747
Herman P, Krüger JA, Perini MV, Coelho FF, Lupinacci RM (2013) Laparoscopic hepatic posterior sectionectomy: a hand-assisted approach. Ann Surg Oncol 20:1266
doi: 10.1245/s10434-012-2750-3 pubmed: 23242817
Lopez-Lopez V, López-Conesa A, Brusadin R, Perez-Flores D, Navarro-Barrios Á, Gomez-Valles P, Cayuela V et al (2022) Pure laparoscopic vs. hand-assisted liver surgery for segments 7 and 8: propensity score matching analysis. Surg Endosc 36:4470–4478
doi: 10.1007/s00464-021-08800-8 pubmed: 34697682
Makdissi FF, Jeismann VB, Kruger JAP, Coelho FF, Ribeiro-Junior U, Cecconello I, Herman P (2017) Hand-assisted Approach as a Model to Teach Complex Laparoscopic Hepatectomies: Preliminary Results. Surg Laparosc Endosc Percutan Tech 27:285–289
doi: 10.1097/SLE.0000000000000424 pubmed: 28767547
Abu-Zaydeh O, Sawaied M, Berger Y, Mahamid A, Goldberg N, Sadot E, Haddad R (2021) Hand-assisted laparoscopic surgery is superior to open liver resection for colorectal liver metastases in the posterosuperior segments. Front Surg 8:746427
doi: 10.3389/fsurg.2021.746427 pubmed: 34901138 pmcid: 8654808
Wabitsch S, Schöning W, Kästner A, Haber PK, Benzing C, Krenzien F, Lenz K et al (2021) A propensity-matched study of full laparoscopic versus hand-assisted minimal-invasive liver surgery. Surg Endosc 35:2021–2028
doi: 10.1007/s00464-020-07597-2 pubmed: 32347389
Yoh T, Seo S, Ogiso S, Morino K, Nishio T, Koyama Y, Fukumitsu K et al (2022) Learning process of laparoscopic liver resection and postoperative outcomes: chronological analysis of single-center 15-years’ experience. Surg Endosc 36:3398–3406
doi: 10.1007/s00464-021-08660-2 pubmed: 34312730
Koffron AJ, Auffenberg G, Kung R, Abecassis M (2007) Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246:385–392 (discussion 392-384)
doi: 10.1097/SLA.0b013e318146996c pubmed: 17717442 pmcid: 1959347
Ciria R, Berardi G, Nishino H, Chan ACY, Chanwat R, Chen KH, Chen Y et al (2022) A snapshot of the 2020 conception of anatomic liver resections and their applicability on minimally invasive liver surgery. A preparatory survey for the Expert Consensus Meeting on Precision Anatomy for Minimally Invasive HBP Surgery. J Hepato-Biliary Pancreat Sci 29:41–50
doi: 10.1002/jhbp.959
Cuschieri A (2000) Laparoscopic hand-assisted surgery for hepatic and pancreatic disease. Surg Endosc 14:991–996
doi: 10.1007/s004640080120 pubmed: 11116403
Hasegawa Y, Koffron AJ, Buell JF, Wakabayashi G (2015) Approaches to laparoscopic liver resection: a meta-analysis of the role of hand-assisted laparoscopic surgery and the hybrid technique. J Hepato-Biliary Pancreat Sci 22:335–341
doi: 10.1002/jhbp.214
Fiorentini G, Swaid F, Cipriani F, Ratti F, Heres C, Tsung A, Aldrighetti L et al (2019) Propensity score-matched analysis of pure laparoscopic versus hand-assisted/hybrid major hepatectomy at two western centers. World J Surg 43:2025–2037
doi: 10.1007/s00268-019-04998-w pubmed: 30953196
Cardinal JS, Reddy SK, Tsung A, Marsh JW, Geller DA (2013) Laparoscopic major hepatectomy: pure laparoscopic approach versus hand-assisted technique. J Hepato-Biliary Pancreat Sci 20:114–119
doi: 10.1007/s00534-012-0553-3
Dagher I, Gayet B, Tzanis D, Tranchart H, Fuks D, Soubrane O, Han HS et al (2014) International experience for laparoscopic major liver resection. J Hepato-Biliary Pancreat Sci 21:732–736
doi: 10.1002/jhbp.140
Barabino M, Piccolo G, Opocher E (2022) Laparoscopic thermal ablation for colorectal liver metastases: technical tips and pitfalls. Laparosc Surg 6:19
doi: 10.21037/ls-22-12
Hariharan D, Constantinides V, Kocher HM, Tekkis PP (2012) The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of patients with resectable colorectal liver metastases: a meta-analysis. Am J Surg 204:84–92
doi: 10.1016/j.amjsurg.2011.07.018 pubmed: 22244586
Laurent C, Adam JP, Denost Q, Smith D, Saric J, Chiche L (2016) Significance of R1 resection for advanced colorectal liver metastases in the era of modern effective chemotherapy. World J Surg 40:1191–1199
doi: 10.1007/s00268-016-3404-6 pubmed: 26757718
Pencovich N, Houli R, Lubezky N, Goykhman Y, Nakache R, Klausner JM, Nachmany I (2019) R1 resection of colorectal liver metastasis—What is the cost of marginal resection? J Surg Oncol 119:347–354
pubmed: 30548552
Andreou A, Knitter S, Schmelzle M, Kradolfer D, Maurer MH, Auer TA, Fehrenbach U et al (2021) Recurrence at surgical margin following hepatectomy for colorectal liver metastases is not associated with R1 resection and does not impact survival. Surgery 169:1061–1068
doi: 10.1016/j.surg.2020.11.024 pubmed: 33386128
Martínez-Cecilia D, Wicherts DA, Cipriani F, Berardi G, Barkhatov L, Lainas P, D’Hondt M et al (2021) Impact of resection margins for colorectal liver metastases in laparoscopic and open liver resection: a propensity score analysis. Surg Endosc 35:809–818
doi: 10.1007/s00464-020-07452-4 pubmed: 32107633
Aghayan DL, Kazaryan AM, Dagenborg VJ, Røsok BI, Fagerland MW, Waaler Bjørnelv GM, Kristiansen R et al (2021) Long-term oncologic outcomes after laparoscopic versus open resection for colorectal liver metastases : a randomized trial. Ann Intern Med 174:175–182
doi: 10.7326/M20-4011 pubmed: 33197213
Robles-Campos R, Lopez-Lopez V, Brusadin R, Lopez-Conesa A, Gil-Vazquez PJ, Navarro-Barrios Á, Parrilla P (2019) Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): a prospective randomized controlled trial. Surg Endosc 33:3926–3936
doi: 10.1007/s00464-019-06679-0 pubmed: 30701365
Beppu T, Wakabayashi G, Hasegawa K, Gotohda N, Mizuguchi T, Takahashi Y, Hirokawa F et al (2015) Long-term and perioperative outcomes of laparoscopic versus open liver resection for colorectal liver metastases with propensity score matching: a multi-institutional Japanese study. J Hepato-Biliary Pancreat Sci 22:711–720
doi: 10.1002/jhbp.261

Auteurs

Victor Lopez-Lopez (V)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain. victorrelopez@gmail.com.

Jaime Arthur Pirola Krürger (JAP)

Serviço de Cirurgia do Fígado, Divisão de Cirurgia do Aparelho Digestivo, Departamento de Gastroenterologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Christopher Kuemmerli (C)

Department of Surgery, Clarunis-University Centre for Gastrointestinal and Liver Diseases Basel, Basel, Switzerland.

Samer Tohme (S)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA.

Concepción Gómez-Gavara (C)

Department of HPB Surgery and Transplants, Vall d'Hebron University Hospital, Barcelona Autonomic University, Barcelona, Spain.

Maria Iniesta (M)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain.

Asuncion López-Conesa (A)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain.

Epameinondas Dogeas (E)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA.

Mar Dalmau (M)

Department of HPB Surgery and Transplants, Vall d'Hebron University Hospital, Barcelona Autonomic University, Barcelona, Spain.

Roberto Brusadin (R)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain.

Ignacio Sánchez-Esquer (I)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain.

David A Geller (DA)

Department of Surgery, University of Pittsburgh, Pittsburgh, PA, 15213, USA.

Paulo Herman (P)

Serviço de Cirurgia do Fígado, Divisão de Cirurgia do Aparelho Digestivo, Departamento de Gastroenterologia, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Ricardo Robles-Campos (R)

Department of General, Visceral and Transplantation Surgery, Clinic and University Hospital Virgen de La Arrixaca, IMIB-ARRIXACA, Ctra. Madrid-Cartagena, s/n, El Palmar, 30120, Murcia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH